↓ Skip to main content

Agranulocytosis associated with dipyrone (metamizol)

Overview of attention for article published in European Journal of Clinical Pharmacology, December 2004
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#30 of 1,783)
  • High Attention Score compared to outputs of the same age (93rd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

news
1 news outlet
twitter
17 tweeters

Citations

dimensions_citation
100 Dimensions

Readers on

mendeley
57 Mendeley
Title
Agranulocytosis associated with dipyrone (metamizol)
Published in
European Journal of Clinical Pharmacology, December 2004
DOI 10.1007/s00228-004-0836-y
Pubmed ID
Authors

Luisa Ib��ez, Xavier Vidal, Elena Ballar�n, Joan-Ramon Laporte

Abstract

Reported estimates of the risk of agranulocytosis associated with metamizol have varied by several orders of magnitude. We assessed this association in a large database for the surveillance of blood dyscrasias.

Twitter Demographics

The data shown below were collected from the profiles of 17 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 57 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 2%
Brazil 1 2%
Unknown 55 96%

Demographic breakdown

Readers by professional status Count As %
Researcher 9 16%
Unspecified 8 14%
Student > Master 8 14%
Other 6 11%
Student > Postgraduate 6 11%
Other 20 35%
Readers by discipline Count As %
Medicine and Dentistry 31 54%
Unspecified 12 21%
Pharmacology, Toxicology and Pharmaceutical Science 6 11%
Agricultural and Biological Sciences 3 5%
Psychology 1 2%
Other 4 7%

Attention Score in Context

This research output has an Altmetric Attention Score of 23. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 November 2018.
All research outputs
#642,191
of 12,936,999 outputs
Outputs from European Journal of Clinical Pharmacology
#30
of 1,783 outputs
Outputs of similar age
#11,425
of 189,916 outputs
Outputs of similar age from European Journal of Clinical Pharmacology
#3
of 20 outputs
Altmetric has tracked 12,936,999 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,783 research outputs from this source. They receive a mean Attention Score of 4.5. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 189,916 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.